Doç. Dr. Mahir Kapmaz
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
COVID-19 5 publicationsSource: OpenAlex / PubMed MeSHView publications
- Klebsiella Infections 4 publications
- Bacteremia 2 publications
- Mycoses 2 publications
- Influenza, Human 2 publications
CV
Education and experience
Experience
- ExperienceBitlis Devlet Hastanesimedipol.com.tr
- ExperienceYenibosna Safa Hastanesimedipol.com.tr
- ExperienceKoç Üniversitesi Hastanesimedipol.com.tr
Education
- 2011İstanbul Üniversitesi İstanbul Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyolojimedipol.com.tr
- 2003Hacettepe Üniversitesi, Tıp Fakültesimedipol.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyInfectious Diseases and Clinical Microbiologymedipol.com.trFrom source
- InstitutionMedipol Mega Üniversite Hastanesimedipol.com.trFrom source
- Area of workCOVID-19Extracted from 5 publications · Model version —From source
- Publications125 publicationsOpenAlexFrom source
- Languagesİngilizcemedipol.com.trFrom source
- Last synchronised4 November 2026 20:26https://medipol.com.tr/doktorlarimiz/docdr-mahir-kapmazmedipol.com.tr
Scientific work
Publications on COVID-19
-
Analysis of Bacteremic Brucellosis Caused by Brucella melitensis Biovar 3 vs. Non-Bacteremic Cases in an Endemic Region of Türkiye
Infectious Diseases and Clinical Microbiology, 2026
DOI 10.36519/idcm.2026.816 PMID 41809933 Open-access full textSource: OpenAlex
-
Stewart-Treves Syndrome Misdiagnosed as Cellulitis Following the 2023 Kahramanmaraş Earthquake
Infectious Diseases and Clinical Microbiology, 2026
DOI 10.36519/idcm.2026.834 PMID 42327523 Open-access full textSource: OpenAlex
-
The first outbreak of neuroinvasive West Nile virus infection in Istanbul area within 2019
BMC Infectious Diseases, 2026
DOI 10.1186/s12879-026-13073-4 PMID 41826887 Open-access full textSource: OpenAlex
-
Effectiveness and safety of molnupiravir among patients with mild to moderate COVID-19: a prospective, observational, cohort study
Scientific Reports, 2026
DOI 10.1038/s41598-026-44971-x PMID 41991956 Open-access full textSource: OpenAlex
-
Predictors and mortality in PCR-positive pneumocystis pneumonia among non-HIV patients
BMC Infectious Diseases, 2026
DOI 10.1186/s12879-026-13884-5 PMID 42380877 Open-access full textSource: OpenAlex
-
Post-treatment paradoxical reaction in tuberculous flexor tenosynovitis with rice bodies after a cat bite
Revista do Instituto de Medicina Tropical de São Paulo, 2026
DOI 10.1590/s1678-9946202668042 PMID 42417799 Open-access full textSource: OpenAlex
-
Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence
Medicina, 2025
DOI 10.3390/medicina61081373 PMID 40870416 Open-access full textSource: OpenAlex
-
The Analysis of Missed Antibiotic De-Escalation Opportunities in Gram-Negative Bloodstream Infections
Antibiotics, 2025
DOI 10.3390/antibiotics14080800 PMID 40867994 Open-access full textSource: OpenAlex
-
The impact of commonly administered ceftriaxone, piperacillin-tazobactam, and imipenem-cilastatin on human candida colonization
Experimental Biomedical Research, 2025
DOI 10.30714/j-ebr.2025.261 Source: OpenAlex
-
Analysis of an outbreak of echinocandin-resistant clonal Candida parapsilosis complex harbouring ERG11Y132F and FKS1S656P mutations
Journal of Hospital Infection, 2025
DOI 10.1016/j.jhin.2025.10.013 PMID 41167425 Source: OpenAlex